Predictive Genetic Testing and Consumer Genomics Market Size, Share and Growth Outlook 2026: By Test Type (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application, By Setting, Companies to 2034.
The global Predictive Genetic Testing and Consumer Genomics Market size is forecast to increase from $5.43 Billion in 2026 to $13.07 Billion in 2034 at a CAGR of 11.6% between 2026 and 2034.
The Predictive Genetic Testing and Consumer Genomics market report provides detailed analysis and outlook of Predictive Genetic Testing and Consumer Genomics segments including By Test Type (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application (Cancer Screening, Cardiovascular Screening, Musculoskeletal Screening, Diabetic Screening and Monitoring, Parkinson’s/Alzheimer’s Disease Screening, Other Applications), By Setting (Direct-to-Consumer (DTC), Hospitals and Clinics, Diagnostic Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Predictive Genetic Testing and Consumer Genomics Industry Overview
Clinical Genomics and Consumer Genetics are Converging into Integrated Precision Healthcare Ecosystems
The Predictive Genetic Testing and Consumer Genomics industry is undergoing a structural transformation as clinical diagnostics, precision oncology, artificial intelligence, and consumer genomics increasingly converge into unified healthcare ecosystems. The market is shifting beyond traditional hereditary risk screening and ancestry testing toward longitudinal health prediction, treatment monitoring, pharmacogenomics, and personalized therapeutic selection. Advances in next-generation sequencing, liquid biopsy technologies, artificial intelligence-based interpretation platforms, and large-scale genomic databases are enabling healthcare providers and consumers to utilize genomic information throughout the entire patient journey, from disease risk assessment and early detection to therapy optimization and outcome prediction. This evolution is driving substantial growth in oncology testing, molecular residual disease monitoring, predictive biomarker discovery, and consumer-driven precision medicine applications.
Precision Oncology and Artificial Intelligence are Expanding the Clinical Utility of Predictive Genetic Testing
Precision oncology continues to represent the fastest-evolving segment within predictive genomics, with growing emphasis on molecular residual disease (MRD) monitoring, AI-enabled risk stratification, and treatment selection tools. The increasing adoption of personalized cancer management strategies has accelerated demand for highly sensitive genomic assays capable of supporting both early detection and longitudinal disease surveillance. This trend is reflected by Natera's achievement of processing more than one million tests during a single quarter, including approximately 258,900 oncology assays, with strong market adoption of its Signatera and Fetal Focus platforms driving significant testing volume growth. Similarly, Myriad Genetics is expanding the role of predictive oncology diagnostics through the commercialization of its Precise MRD breast cancer assay and the development of an artificial intelligence-enhanced Prolaris prostate cancer test in partnership with PATHOMIQ, highlighting the increasing integration of machine learning technologies into predictive cancer diagnostics and treatment planning.
Consumer Genomics Platforms are Expanding Toward Pharmacogenomics and Personalized Therapeutic Prediction
The consumer genomics market is simultaneously evolving from recreational genetic testing toward clinically actionable health intelligence and therapeutic response prediction. Large-scale genomic datasets combined with advanced computational analytics are enabling researchers to identify genetic factors that influence treatment efficacy, adverse events, and disease susceptibility. The 23andMe Research Institute's recent genomic investigation into differential responses to GLP-1 receptor agonists illustrates this broader industry transition toward pharmacogenomics and precision therapeutics. These capabilities are expected to expand the role of consumer genomic databases beyond risk assessment into personalized drug selection, metabolic health management, and predictive healthcare modeling. As artificial intelligence, molecular diagnostics, and consumer health technologies continue to converge, predictive genetic testing is increasingly becoming a foundational component of next-generation precision medicine infrastructure.
Predictive Genetic Testing and Consumer Genomics Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Predictive Genetic Testing and Consumer Genomics market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- 23andMe, Inc. , AncestryDNA (Ancestry.com LLC) , MyHeritage Ltd. , Helix OpCo LLC , Illumina, Inc. , Color Health, Inc. , Nebula Genomics (BGI Group) , Gene by Gene, Ltd. , Invitae Corporation , Pathway Genomics. The Predictive Genetic Testing and Consumer Genomics market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Predictive Genetic Testing and Consumer Genomics industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Predictive Genetic Testing and Consumer Genomics industry include- 23andMe, Inc. , AncestryDNA (Ancestry.com LLC) , MyHeritage Ltd. , Helix OpCo LLC , Illumina, Inc. , Color Health, Inc. , Nebula Genomics (BGI Group) , Gene by Gene, Ltd. , Invitae Corporation , Pathway Genomics. The Predictive Genetic Testing and Consumer Genomics market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Predictive Genetic Testing and Consumer Genomics Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Predictive Genetic Testing and Consumer Genomics market remains one of the strongest-performing segments in the country.
The US Predictive Genetic Testing and Consumer Genomics Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Predictive Genetic Testing and Consumer Genomics market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Predictive Genetic Testing and Consumer Genomics industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Predictive Genetic Testing and Consumer Genomics markets
Canada's strong Predictive Genetic Testing and Consumer Genomics sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Predictive Genetic Testing and Consumer Genomics market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Predictive Genetic Testing and Consumer Genomics Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Predictive Genetic Testing and Consumer Genomics market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Predictive Genetic Testing and Consumer Genomics population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Predictive Genetic Testing and Consumer Genomics industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Predictive Genetic Testing and Consumer Genomics market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Predictive Genetic Testing and Consumer Genomics sales through 2034
France Predictive Genetic Testing and Consumer Genomics companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Predictive Genetic Testing and Consumer Genomics Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Predictive Genetic Testing and Consumer Genomics distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Predictive Genetic Testing and Consumer Genomics Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Predictive Genetic Testing and Consumer Genomics market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Predictive Genetic Testing and Consumer Genomics industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Predictive Genetic Testing and Consumer Genomics industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Predictive Genetic Testing and Consumer Genomics Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Predictive Genetic Testing and Consumer Genomics market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Predictive Genetic Testing and Consumer Genomics market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Predictive Genetic Testing and Consumer Genomics Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Predictive Genetic Testing and Consumer Genomics Market Segmentation
By Test Type
Predictive Testing
Consumer Genomics
Wellness Genomics
By Application
Cancer Screening
Cardiovascular Screening
Musculoskeletal Screening
Diabetic Screening and Monitoring
Parkinson’s/Alzheimer’s Disease Screening
Other Applications
By Setting
Direct-to-Consumer (DTC)
Hospitals and Clinics
Diagnostic Laboratories
Leading Companies in Predictive Genetic Testing and Consumer Genomics Industry (2026)
23andMe, Inc.
AncestryDNA (Ancestry.com LLC)
MyHeritage Ltd.
Helix OpCo LLC
Illumina, Inc.
Color Health, Inc.
Nebula Genomics (BGI Group)
Gene by Gene, Ltd.
Invitae Corporation
Pathway Genomics
Countries Included
The Predictive Genetic Testing and Consumer Genomics market report provides detailed analysis and outlook of Predictive Genetic Testing and Consumer Genomics segments including By Test Type (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application (Cancer Screening, Cardiovascular Screening, Musculoskeletal Screening, Diabetic Screening and Monitoring, Parkinson’s/Alzheimer’s Disease Screening, Other Applications), By Setting (Direct-to-Consumer (DTC), Hospitals and Clinics, Diagnostic Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Predictive Genetic Testing and Consumer Genomics Industry Overview
Clinical Genomics and Consumer Genetics are Converging into Integrated Precision Healthcare Ecosystems
The Predictive Genetic Testing and Consumer Genomics industry is undergoing a structural transformation as clinical diagnostics, precision oncology, artificial intelligence, and consumer genomics increasingly converge into unified healthcare ecosystems. The market is shifting beyond traditional hereditary risk screening and ancestry testing toward longitudinal health prediction, treatment monitoring, pharmacogenomics, and personalized therapeutic selection. Advances in next-generation sequencing, liquid biopsy technologies, artificial intelligence-based interpretation platforms, and large-scale genomic databases are enabling healthcare providers and consumers to utilize genomic information throughout the entire patient journey, from disease risk assessment and early detection to therapy optimization and outcome prediction. This evolution is driving substantial growth in oncology testing, molecular residual disease monitoring, predictive biomarker discovery, and consumer-driven precision medicine applications.
Precision Oncology and Artificial Intelligence are Expanding the Clinical Utility of Predictive Genetic Testing
Precision oncology continues to represent the fastest-evolving segment within predictive genomics, with growing emphasis on molecular residual disease (MRD) monitoring, AI-enabled risk stratification, and treatment selection tools. The increasing adoption of personalized cancer management strategies has accelerated demand for highly sensitive genomic assays capable of supporting both early detection and longitudinal disease surveillance. This trend is reflected by Natera's achievement of processing more than one million tests during a single quarter, including approximately 258,900 oncology assays, with strong market adoption of its Signatera and Fetal Focus platforms driving significant testing volume growth. Similarly, Myriad Genetics is expanding the role of predictive oncology diagnostics through the commercialization of its Precise MRD breast cancer assay and the development of an artificial intelligence-enhanced Prolaris prostate cancer test in partnership with PATHOMIQ, highlighting the increasing integration of machine learning technologies into predictive cancer diagnostics and treatment planning.
Consumer Genomics Platforms are Expanding Toward Pharmacogenomics and Personalized Therapeutic Prediction
The consumer genomics market is simultaneously evolving from recreational genetic testing toward clinically actionable health intelligence and therapeutic response prediction. Large-scale genomic datasets combined with advanced computational analytics are enabling researchers to identify genetic factors that influence treatment efficacy, adverse events, and disease susceptibility. The 23andMe Research Institute's recent genomic investigation into differential responses to GLP-1 receptor agonists illustrates this broader industry transition toward pharmacogenomics and precision therapeutics. These capabilities are expected to expand the role of consumer genomic databases beyond risk assessment into personalized drug selection, metabolic health management, and predictive healthcare modeling. As artificial intelligence, molecular diagnostics, and consumer health technologies continue to converge, predictive genetic testing is increasingly becoming a foundational component of next-generation precision medicine infrastructure.
Predictive Genetic Testing and Consumer Genomics Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Predictive Genetic Testing and Consumer Genomics market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- 23andMe, Inc. , AncestryDNA (Ancestry.com LLC) , MyHeritage Ltd. , Helix OpCo LLC , Illumina, Inc. , Color Health, Inc. , Nebula Genomics (BGI Group) , Gene by Gene, Ltd. , Invitae Corporation , Pathway Genomics. The Predictive Genetic Testing and Consumer Genomics market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Predictive Genetic Testing and Consumer Genomics industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Predictive Genetic Testing and Consumer Genomics Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Predictive Genetic Testing and Consumer Genomics companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Predictive Genetic Testing and Consumer Genomics markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Predictive Genetic Testing and Consumer Genomics industry include- 23andMe, Inc. , AncestryDNA (Ancestry.com LLC) , MyHeritage Ltd. , Helix OpCo LLC , Illumina, Inc. , Color Health, Inc. , Nebula Genomics (BGI Group) , Gene by Gene, Ltd. , Invitae Corporation , Pathway Genomics. The Predictive Genetic Testing and Consumer Genomics market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Predictive Genetic Testing and Consumer Genomics Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Predictive Genetic Testing and Consumer Genomics market remains one of the strongest-performing segments in the country.
The US Predictive Genetic Testing and Consumer Genomics Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Predictive Genetic Testing and Consumer Genomics market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Predictive Genetic Testing and Consumer Genomics industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Predictive Genetic Testing and Consumer Genomics markets
Canada's strong Predictive Genetic Testing and Consumer Genomics sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Predictive Genetic Testing and Consumer Genomics market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Predictive Genetic Testing and Consumer Genomics Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Predictive Genetic Testing and Consumer Genomics market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Predictive Genetic Testing and Consumer Genomics population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Predictive Genetic Testing and Consumer Genomics industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Predictive Genetic Testing and Consumer Genomics market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Predictive Genetic Testing and Consumer Genomics sales through 2034
France Predictive Genetic Testing and Consumer Genomics companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Predictive Genetic Testing and Consumer Genomics Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Predictive Genetic Testing and Consumer Genomics distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Predictive Genetic Testing and Consumer Genomics Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Predictive Genetic Testing and Consumer Genomics market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Predictive Genetic Testing and Consumer Genomics industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Predictive Genetic Testing and Consumer Genomics industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Predictive Genetic Testing and Consumer Genomics Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Predictive Genetic Testing and Consumer Genomics market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Predictive Genetic Testing and Consumer Genomics market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Predictive Genetic Testing and Consumer Genomics Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Predictive Genetic Testing and Consumer Genomics Market Segmentation
By Test Type
Predictive Testing
Consumer Genomics
Wellness Genomics
By Application
Cancer Screening
Cardiovascular Screening
Musculoskeletal Screening
Diabetic Screening and Monitoring
Parkinson’s/Alzheimer’s Disease Screening
Other Applications
By Setting
Direct-to-Consumer (DTC)
Hospitals and Clinics
Diagnostic Laboratories
Leading Companies in Predictive Genetic Testing and Consumer Genomics Industry (2026)
23andMe, Inc.
AncestryDNA (Ancestry.com LLC)
MyHeritage Ltd.
Helix OpCo LLC
Illumina, Inc.
Color Health, Inc.
Nebula Genomics (BGI Group)
Gene by Gene, Ltd.
Invitae Corporation
Pathway Genomics
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Predictive Genetic Testing and Consumer Genomics Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Predictive Genetic Testing and Consumer Genomics Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Predictive Genetic Testing and Consumer Genomics Markets in 2026
3.2. Global Historic and Forecast Predictive Genetic Testing and Consumer Genomics Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Predictive Genetic Testing and Consumer Genomics Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Predictive Genetic Testing and Consumer Genomics Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Predictive Genetic Testing and Consumer Genomics Value Chain
CHAPTER 4- PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Predictive Genetic Testing and Consumer Genomics Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Test Type
Predictive Testing
Consumer Genomics
Wellness Genomics
By Application
Cancer Screening
Cardiovascular Screening
Musculoskeletal Screening
Diabetic Screening and Monitoring
Parkinson’s/Alzheimer’s Disease Screening
Other Applications
By Setting
Direct-to-Consumer (DTC)
Hospitals and Clinics
Diagnostic Laboratories
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
7.5. North America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
7.6. North America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
7.7. North America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Predictive Genetic Testing and Consumer Genomics Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Predictive Genetic Testing and Consumer Genomics Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 8- EUROPE PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
8.5. Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
8.6. Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
8.7. Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Predictive Genetic Testing and Consumer Genomics Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Predictive Genetic Testing and Consumer Genomics Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Predictive Genetic Testing and Consumer Genomics Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Predictive Genetic Testing and Consumer Genomics Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Predictive Genetic Testing and Consumer Genomics Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 9- ASIA PACIFIC PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
9.6. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
9.7. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Predictive Genetic Testing and Consumer Genomics Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Predictive Genetic Testing and Consumer Genomics Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Predictive Genetic Testing and Consumer Genomics Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Predictive Genetic Testing and Consumer Genomics Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Predictive Genetic Testing and Consumer Genomics Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
10.5. South and Central America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
10.6. South and Central America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
10.7. South and Central America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Predictive Genetic Testing and Consumer Genomics Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Predictive Genetic Testing and Consumer Genomics Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
11.6. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
11.7. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Predictive Genetic Testing and Consumer Genomics Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Predictive Genetic Testing and Consumer Genomics Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Predictive Genetic Testing and Consumer Genomics Industry
23ANDME, INC.
AncestryDNA (Ancestry.com LLC)
MyHeritage Ltd.
Helix OpCo LLC
Illumina, Inc.
Color Health, Inc.
Nebula Genomics (BGI Group)
Gene by Gene, Ltd.
Invitae Corporation
Pathway Genomics
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Predictive Genetic Testing and Consumer Genomics Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Predictive Genetic Testing and Consumer Genomics Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Predictive Genetic Testing and Consumer Genomics Markets in 2026
3.2. Global Historic and Forecast Predictive Genetic Testing and Consumer Genomics Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Predictive Genetic Testing and Consumer Genomics Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Predictive Genetic Testing and Consumer Genomics Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Predictive Genetic Testing and Consumer Genomics Value Chain
CHAPTER 4- PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Predictive Genetic Testing and Consumer Genomics Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Test Type
Predictive Testing
Consumer Genomics
Wellness Genomics
By Application
Cancer Screening
Cardiovascular Screening
Musculoskeletal Screening
Diabetic Screening and Monitoring
Parkinson’s/Alzheimer’s Disease Screening
Other Applications
By Setting
Direct-to-Consumer (DTC)
Hospitals and Clinics
Diagnostic Laboratories
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
7.5. North America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
7.6. North America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
7.7. North America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Predictive Genetic Testing and Consumer Genomics Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Predictive Genetic Testing and Consumer Genomics Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 8- EUROPE PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
8.5. Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
8.6. Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
8.7. Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Predictive Genetic Testing and Consumer Genomics Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Predictive Genetic Testing and Consumer Genomics Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Predictive Genetic Testing and Consumer Genomics Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Predictive Genetic Testing and Consumer Genomics Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Predictive Genetic Testing and Consumer Genomics Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 9- ASIA PACIFIC PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
9.6. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
9.7. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Predictive Genetic Testing and Consumer Genomics Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Predictive Genetic Testing and Consumer Genomics Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Predictive Genetic Testing and Consumer Genomics Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Predictive Genetic Testing and Consumer Genomics Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Predictive Genetic Testing and Consumer Genomics Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
10.5. South and Central America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
10.6. South and Central America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
10.7. South and Central America Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Predictive Genetic Testing and Consumer Genomics Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Predictive Genetic Testing and Consumer Genomics Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Type
11.6. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Application
11.7. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Predictive Genetic Testing and Consumer Genomics Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Predictive Genetic Testing and Consumer Genomics Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Predictive Genetic Testing and Consumer Genomics Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Predictive Genetic Testing and Consumer Genomics Industry
23ANDME, INC.
AncestryDNA (Ancestry.com LLC)
MyHeritage Ltd.
Helix OpCo LLC
Illumina, Inc.
Color Health, Inc.
Nebula Genomics (BGI Group)
Gene by Gene, Ltd.
Invitae Corporation
Pathway Genomics
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
